Evaluating the Efficacy of Annual CHTC Retesting Among Male Couples at High Risk of HIV Infection

The purpose of this study is to evaluate the benefits associated with couples HIV testing and counseling (CHTC) resting. After their 12-month follow-up, those participants who remain in the same relationship they were in at the time of their baseline will be offered the opportunity to continue in the components proposed in this revision. Those who consent will be randomized to either complete a second session of CHTC or to a comparison condition in which both partners receive a routine individual HIV test. HIV positive partners in serodiscordant couples randomized to the control condition will receive information about anti-retroviral treatment adherence and U=U (undetectable = untransmissible). Given potential attrition and rates of relationship dissolution, we anticipate randomizing 200 couples (80% of the original sample). Follow-up assessments will be conducted 3 and 6 months after retesting (15 and 18 months after the participants' original baseline appointment).

Inclusion:

• enrolled previously in the parent study DA050508 (NCT05000866).
• in a relationship with the same main partner with whom they completed the baseline intervention session.
• both partners in the couple must consent to continue with activities specified in this revision.
• completion of the 12-month assessment associated with participation in the parent study prior to consenting to participate in activities specified under this revision.

Exclusion: any of the following at the 12-month follow-up:

• serious psychiatric symptoms;
• current suicidal/homicidal ideation;
• gross cognitive impairment
• a history of severe physical or sexual Intimate Partner Violence (IPV) victimization in the current relationship.